| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/24/2007 | US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/24/2007 | US7247711 For therapy or reducing the symptoms of immune, neurological, and related disorders, such as, but not limited to, multiple sclerosis, rheumatoid arthritis, juvenile rheumatoid arthritis, systemic onset juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondilitis, gastric ulcer |
| 07/24/2007 | US7247710 An amino acid sequence free of its associated signal peptide; fusion proteins, host cell of an E. coli or a yeast cell, immunomodulator, immunostimulants, cell proliferation, tumor detection, receptor binding assay |
| 07/24/2007 | US7247709 Mitogenic oxygenases |
| 07/24/2007 | US7247703 Anticancer agents; protein complex |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/24/2007 | US7247614 Composition and method for modulating somatolactogenic function |
| 07/24/2007 | US7247612 novel cell surface molecules of mammals |
| 07/24/2007 | US7247608 FGF homolog polypeptides |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247476 Isolated monoclonal antibody; patient specific anti-cancer antibodies using a novel paradigm of screening |
| 07/24/2007 | US7247474 Hybridoma cell line; vehicles for combating viral infections and tumors |
| 07/24/2007 | US7247455 Comprises single stranded nucleic acid probe and/or monoclonal antibody for detection of streptococcal infections, as well as, treatment for respiratory system disorders; immunoassays |
| 07/24/2007 | US7247453 Calcium binding recombinant antibody against protein C |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247442 Isolated antibody or fragment that binds to a polypeptide; human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins |
| 07/24/2007 | US7247436 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 07/24/2007 | US7247305 Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 07/24/2007 | US7247304 Methods of treating using anti-IL-15 antibodies |
| 07/24/2007 | US7247303 Antibody that binds to phosphatidyl serine comprising a CDR of the monoclonal antibody 3G4 produced by hybridoma; anticarcinogenic, antitumor, and viricidal agents; angiogenesis inhibitors |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2162134C Hepatitis-c virus type 4,5 and 6 |
| 07/24/2007 | CA2121798C Novel cytokine |
| 07/24/2007 | CA1341536C Transforming growth factor peptides |
| 07/24/2007 | CA1341535C Transforming growth factor peptides |
| 07/23/2007 | CA2637947A1 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 07/19/2007 | WO2007082105A2 Chlamydia vaccine |
| 07/19/2007 | WO2007081906A2 Purification by column-chromatography using eluants containing organic solvents |
| 07/19/2007 | WO2007081465A2 Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation |
| 07/19/2007 | WO2007081302A2 Human glp-1 mimetibodies, compositions, methods and uses |
| 07/19/2007 | WO2007080664A1 Marker of primary malignant central nervous system lymphoma and use thereof |
| 07/19/2007 | WO2007080404A2 Leptin ligand |
| 07/19/2007 | WO2007080392A2 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor |
| 07/19/2007 | WO2007080277A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | WO2007080174A2 Chimeric and humanised anti-human il-13 antibodies |
| 07/19/2007 | WO2007080129A1 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
| 07/19/2007 | WO2007079755A1 Reimmunization and antibody design |
| 07/19/2007 | WO2007079546A1 PHOSPHORYLATED Sp1 ANTIBODIES |
| 07/19/2007 | WO2007048037A3 METHODS FOR GENERATING MONOVALENT IgG |
| 07/19/2007 | WO2007042809A3 Antibody polypeptide library screening and selected antibody polypeptides |
| 07/19/2007 | WO2007017686A3 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 07/19/2007 | WO2007015174A3 Exosome-specific ligands, their preparartion and uses |
| 07/19/2007 | WO2007005874A3 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 07/19/2007 | WO2007002543A3 Antibody formulations having optimized aggregation and fragmentation profiles |
| 07/19/2007 | WO2006124667A3 Compositions and methods for modulating immune responses |
| 07/19/2007 | WO2006116002A9 Tgf beta 1 specific antibodies |
| 07/19/2007 | WO2006079120A3 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use |
| 07/19/2007 | WO2006050159A3 Methods of predicting responsiveness to treatment |
| 07/19/2007 | WO2006034191A3 Tem17 binds to cortactin |
| 07/19/2007 | WO2005072057A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 07/19/2007 | WO2003054144A8 Human ras interacting protein |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167644 Bifunctional energy-reversible acyl-compositions |
| 07/19/2007 | US20070167613 a mobile phase comprising sample is contacted with a multi-modal separation matrix to adsorb undesired compounds while the antibodies remain free in the liquid; requires less time and process steps than the prior art methods |
| 07/19/2007 | US20070167612 Polishing steps used in multi-step protein purification processes |
| 07/19/2007 | US20070167607 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166787 Modulators of regulatory proteins |
| 07/19/2007 | US20070166774 Functional immunoassay |
| 07/19/2007 | US20070166773 Compositions and methods for early pregnancy diagnosis |
| 07/19/2007 | US20070166764 Reagents for the detection of phosphorylated ATR kinase (Ser 428/Ser 2317) and uses thereof |
| 07/19/2007 | US20070166756 Polypeptides and polynucleotides encoding same |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166746 Human cytokine receptor |
| 07/19/2007 | US20070166737 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166699 Combination of anti-hpv-16 and 18 antibodies and uses thereof |
| 07/19/2007 | US20070166331 Modified seb and prophylactics/remedies for immunopathy containing the same |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | US20070166312 Antibody against tumor specific antigen as target |
| 07/19/2007 | US20070166311 Monoclonal antibody |
| 07/19/2007 | US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing |
| 07/19/2007 | US20070166309 Tumor necrosis factor receptor specific immunoglobulin for use in treatment and prevention of infection, autoimmune, inflammatory and cell proliferative disorders |
| 07/19/2007 | US20070166308 Monoclonal antibody specific to mucosal addressin cell adhesion molecule (MAdCAM) for use in prevention and treatment of inflammatory, gastrointestinal, liver disorders |
| 07/19/2007 | US20070166307 Suppression of transplant rejection |
| 07/19/2007 | US20070166305 Human estrogen receptor specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2007 | US20070166304 Method of Modulating the Activity of Functional Immune Molecules |
| 07/19/2007 | US20070166303 Ganglioside (GD3) specific immunoglobulin for diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2007 | US20070166302 Chemokine receptor-4 (CXCR4) specific immunoglobulin for diagnosis, prevention and treatment of viral or bacterial infection |
| 07/19/2007 | US20070166301 Method of Modulating the Activity of Functional Immune Molecules |
| 07/19/2007 | US20070166300 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains |
| 07/19/2007 | US20070166290 CNS glial restricted precursor cells which generate oligodendrocytes and at least two distinct populations of astrocytes, but not neurons; isolated from a mixture of cells by positive immunoselection with an A2B5 antibody |
| 07/19/2007 | DE10157336B4 Verfahren zur Herstellung eines Testsystems und Diagnoseverfahren zur Erkennung von Pankreasfunktionsstörungen A process for producing a test system, and diagnostic methods for the detection of pancreatic dysfunction |
| 07/19/2007 | CA2640932A1 Methods for diagnosing and treating prostate cancer |
| 07/19/2007 | CA2636742A1 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor |
| 07/19/2007 | CA2636417A1 Regulators of nfat |
| 07/19/2007 | CA2636109A1 Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents |
| 07/19/2007 | CA2635972A1 Chimeric and humanised anti-human il-13 antibodies |
| 07/19/2007 | CA2633080A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | CA2630220A1 Norovirus and sapovirus antigens |
| 07/19/2007 | CA2603359A1 Human glp-1 mimetibodies, compositions, methods and uses |
| 07/18/2007 | EP1808446A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 07/18/2007 | EP1808445A2 A receptor protein tyrosine kinase |
| 07/18/2007 | EP1808439A2 Epiligrin, an epithelial ligand for integrins |
| 07/18/2007 | EP1808182A1 Lim mineralization protein splice variants |
| 07/18/2007 | EP1807451A2 Hk1-binding proteins |